• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION SUPARTZ FX; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION SUPARTZ FX; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Model Number 89130-4444-01
Device Problem Insufficient Information (3190)
Patient Problem Thrombosis/Thrombus (4440)
Event Type  Injury  
Manufacturer Narrative
A pharmacy reported this case to the us partner; bioventus on (b)(6) 2023.The reporter considered this case as "serious injury" even though the case information was insufficient.We selected the code of (b)(4) (appropriate term/code not available) for manufacturer evaluation conclusion code, because the reported adverse event was not listed in the package insert.
 
Event Description
On (b)(6) 2022, a 56 year-old male patient received supartz fx injection for osteoarthritis into left knee.The patient had a medical history of acute embolism and thrombosis of unspecified deep veins of lower extremity.Unk - the patient reported having a blood clot in his left leg to his pharmacy.The patients therapy was still on-going.It is also reported that the patient received one injection intra-articularly into right knee once per week.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPARTZ FX
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORPORATION
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0 005
JA  100-0005
Manufacturer (Section G)
SEIKAGAKU CORPORATION - TAKAHAGI PLANT
258-5, aza-matsukubo
oaza-akahama
takahagi-shi, ibaraki 318-0 001
JA   318-0001
Manufacturer Contact
pharmacovigilance dept
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0-005
JA   100-0005
MDR Report Key16403655
MDR Text Key310007606
Report Number9612392-2023-00001
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P980044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number89130-4444-01
Device Catalogue Number7156-4444
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/04/2023
Initial Date FDA Received02/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age56 YR
Patient SexMale
-
-